NO20083064L - Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt - Google Patents

Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt

Info

Publication number: NO20083064L
Authority: NO; Norway
Prior art keywords: preparation; enantiomers; formula; pharmaceutical intermediate; levocetirizine
Prior art date: 2005-12-08

Application number

NO20083064A

Other languages

English (en)

Norwegian (no)

Inventor

Zoltan Katona

Gyorgyi Vereczkeyne Donath

Peter Trinka

Jozsef Reiter

Ferenc Bartha

Original Assignee

Egis Gyogyszergyar Nyilvanosan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-08

Filing date

2008-07-08

Publication date

2008-07-08

2008-07-08 Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan

2008-07-08 Publication of NO20083064L publication Critical patent/NO20083064L/no

Links

238000000034 method Methods 0.000 title abstract 2
239000012450 pharmaceutical intermediate Substances 0.000 title abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 abstract 1
ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 abstract 1
206010039897 Sedation Diseases 0.000 abstract 1
GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000001387 anti-histamine Effects 0.000 abstract 1
239000000739 antihistaminic agent Substances 0.000 abstract 1
229960001803 cetirizine Drugs 0.000 abstract 1
238000006243 chemical reaction Methods 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229960001508 levocetirizine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

NO20083064A 2005-12-08 2008-07-08 Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt NO20083064L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0501138A HU227325B1 (en)	2005-12-08	2005-12-08	Process for the production of an intermediate of (dextro- and levo)- cetirizine
PCT/HU2006/000108 WO2007066162A1 (en)	2005-12-08	2006-12-08	Process for the preparation of a pharmaceutical intermediate

Publications (1)

Publication Number	Publication Date
NO20083064L true NO20083064L (no)	2008-07-08

Family

ID=89986438

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20083064A NO20083064L (no)	2005-12-08	2008-07-08	Fremgangsmate for fremstilling av et farmasoytisk mellomprodukt

Country Status (11)

Country	Link
US (1)	US20090018337A1 (de)
EP (1)	EP1971585B1 (de)
JP (1)	JP2009518378A (de)
CN (1)	CN101360727A (de)
AT (1)	ATE501131T1 (de)
DE (1)	DE602006020624D1 (de)
EA (1)	EA014530B1 (de)
HU (1)	HU227325B1 (de)
NO (1)	NO20083064L (de)
UA (1)	UA92770C2 (de)
WO (1)	WO2007066162A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7880761B2 (en)	2005-07-20	2011-02-01	Lab Partners Associates, Inc.	Wireless photographic communication system and method
WO2008150902A1 (en)	2007-05-29	2008-12-11	Lab Partners Associates, Inc.	System and method for maintaining hot shoe communications between a camera and a wireless device
WO2009022327A2 (en)	2007-08-15	2009-02-19	Chemagis Ltd.	Novel process for preparing highly pure levocetirizine and salts thereof
CN103044355A (zh) *	2011-10-13	2013-04-17	湖南九典制药有限公司	合成左西替利嗪的关键中间体及其制备方法
CN110988163B (zh) *	2019-11-29	2022-04-19	重庆华邦胜凯制药有限公司	一种hplc法分离测定盐酸左西替利嗪及其基因毒性杂质e的方法
CN111205247B (zh) *	2020-04-22	2020-08-14	湖南九典宏阳制药有限公司	左旋西替利嗪的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO155805C (no) *	1981-02-06	1987-06-10	Ucb Sa	Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
GB8827391D0 (en) *	1988-11-23	1988-12-29	Ucb Sa	Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US20030064995A1 (en) *	2001-10-03	2003-04-03	Merck Patent Gmbh	Amide and urea derivatives as 5-HT reuptake inhibitors and as5-HT1B/1D ligands
IL124195A (en) *	1998-04-23	2000-08-31	Chemagis Ltd	Process for the preparation of esters of 2-¬4-¬4-chlorophenyl¾phenylmethyl¾-1-piperazinyl¬ethoxy¾acetic acid
HRP20020470B1 (hr) *	1999-11-30	2009-04-30	Egis Gy�gyszergy�r RT	POSTUPAK PRIREĐIVANJA {2-[4-(α-FENIL-p-KLORBENZIL)-PIPERAZIN-1-IL]ETOKSI} OCTENE KISELINE I NOVIH INTERMEDIJERA

2005
- 2005-12-08 HU HU0501138A patent/HU227325B1/hu not_active IP Right Cessation
2006
- 2006-08-12 UA UAA200808850A patent/UA92770C2/ru unknown
- 2006-12-08 JP JP2008543922A patent/JP2009518378A/ja not_active Withdrawn
- 2006-12-08 AT AT06842191T patent/ATE501131T1/de not_active IP Right Cessation
- 2006-12-08 EA EA200801505A patent/EA014530B1/ru not_active IP Right Cessation
- 2006-12-08 WO PCT/HU2006/000108 patent/WO2007066162A1/en not_active Ceased
- 2006-12-08 US US12/096,630 patent/US20090018337A1/en not_active Abandoned
- 2006-12-08 DE DE602006020624T patent/DE602006020624D1/de active Active
- 2006-12-08 EP EP06842191A patent/EP1971585B1/de active Active
- 2006-12-08 CN CNA2006800455299A patent/CN101360727A/zh active Pending
2008
- 2008-07-08 NO NO20083064A patent/NO20083064L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20090018337A1 (en)	2009-01-15
EP1971585B1 (de)	2011-03-09
HU227325B1 (en)	2011-03-28
ATE501131T1 (de)	2011-03-15
JP2009518378A (ja)	2009-05-07
HUP0501138A2 (en)	2007-08-28
EA200801505A1 (ru)	2008-10-30
HU0501138D0 (en)	2006-02-28
WO2007066162A1 (en)	2007-06-14
UA92770C2 (ru)	2010-12-10
DE602006020624D1 (de)	2011-04-21
CN101360727A (zh)	2009-02-04
EA014530B1 (ru)	2010-12-30
EP1971585A1 (de)	2008-09-24

Similar Documents

Publication	Publication Date	Title
MY148643A (en)	2013-05-15	Solvate and crystalline forms of carbamoyl-cyclohexane derivatives
NO20060110L (no)	2006-02-09	Spesifik glukokortikosteroid forbindelse med anti-inflammatorisk aktivitet
MEP53708A (en)	2011-05-10	3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition
NO20063928L (no)	2006-10-31	Substituerte kinolinforbindelser
NO20080789L (no)	2008-02-13	1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid
NO20090229L (no)	2009-02-12	1-[2-(2,4-dimetylfenylsulfanyl-fenyl]-piperazin som en forbindelse med kombinert serotoninreopptak, 5-HT3- og 5HT1A-aktivitet for behandlingen av kognitiv smerte
NO20072605L (no)	2007-09-05	Nytt antranilinsyrederivat eller et salt derav
NO20063479L (no)	2006-10-02	Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
NO20083068L (no)	2008-07-08	Optisk aktive karbamater, fremgangsmate for deres fremstilling og anvendelse derav som farmasoytiske mellomprodukter
BRPI0514935A (pt)	2008-07-01	composição de higiene pessoal e doméstica e método de usar uma composição de higiene pessoal e doméstica
NO20080186L (no)	2008-03-14	Heterosykliske aspartylproteaseinhibitorer, fremstilling og anvendelse derav
NO20083411L (no)	2004-03-19	Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
US11679093B2 (en)	2023-06-20	2-naphthimidamides, analogues thereof, and methods of treatment using same
MX2010004688A (es)	2010-09-09	Usos terapeuticos de compuestos que tienen actividad combinada de sert, 5- ht3 y 5-ht1a.
MX2007010532A (es)	2007-10-12	Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
NO20080394L (no)	2008-03-14	N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
NO20056192L (no)	2005-12-27	Kapaseinhibitorer og anvendelse derav
MX2010008583A (es)	2010-08-30	Novedosos formas cristalinas de acido 4-[4-(2-adamantilcarbamoil)- 5-ter-butil-pirazol-1-il]benzoico.
BRPI0514731A (pt)	2008-06-24	derivados de pirimidina
ATE457302T1 (de)	2010-02-15	Aromatische etherderivate als thrombin-hemmer
ATE459603T1 (de)	2010-03-15	Pyridinaminosulfonylsubstituierte benzamide als inhibitoren von cytochrom p450 3a4 (cyp3a4)
NO20082411L (no)	2008-07-28	Heterocykliske amidforbindelser og anvendelse derav
HU0501138D0 (en)	2006-02-28	Process for the production of a pharmaceutical intermediate
MX9704128A (es)	1997-12-31	Sales de esteres etilicos de acidos 3-(2-(4-(4-(amino-imino-metil)-fenil)-4-metil-2,5-dioxo-imid azolidin1-il)-acetilamino)-3-fenil-propionicos.
CO5590934A2 (es)	2005-12-30	Procedimiento de preparacion de derivados de equinocandina

Legal Events

Date	Code	Title	Description
2012-07-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application